MyAverix Finance
NS · Pharmaceuticals
Natco Pharma Ltd (NATCOPHARM)
Pharmaceuticals & Biotechnology
Natco Pharma Ltd (NATCOPHARM) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-07, reported market cap is $159.52B, P/E ratio is 12.45, net margin is 36.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NATCOPHARM
Natco Pharma Ltd (NATCOPHARM) — FAQ
What is Natco Pharma Ltd's market cap?
Natco Pharma Ltd (NATCOPHARM) has a reported market cap of $159.52B (data as of 2026-07-07).
What is NATCOPHARM's P/E ratio?
The price-to-earnings (P/E) ratio for Natco Pharma Ltd (NATCOPHARM) is 12.45 (data as of 2026-07-07).
Does Natco Pharma Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Natco Pharma Ltd (NATCOPHARM). Check the MyAverix Finance app for the latest dividend data.
What sector is Natco Pharma Ltd in?
Natco Pharma Ltd (NATCOPHARM) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is NATCOPHARM listed on?
NATCOPHARM is listed on NS.
What is Natco Pharma Ltd's net margin?
Natco Pharma Ltd (NATCOPHARM) reports a net margin of 36.8% (data as of 2026-07-07).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.